AC607, mesenchymal stem cells for treatment of acute kidney injury
AC607 are expanded bone marrow-derived mesenchymal stem cells (MSC), obtained from healthy adult donors using a proprietary manufacturing process. For treatment of acute kidney injury (AKI), AC607 homes to the injured kidney, where it mediates anti-inflammatory and organ repair processes. AC607 avoids recognition by the immune system, enabling administration in an "off-the-shelf" paradigm without the need for tissue typing or immunosuppression.
Read More
Product Information for
AC607, mesenchymal stem cells for treatment of acute kidney injury
Links related to the product - may include a range of information sources (e.g., press releases, websites, patents) related to the specific cell therapy application.
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access